1,042
Views
9
CrossRef citations to date
0
Altmetric
Review

Prospects for a personalized peptide vaccine against lung cancer

, , , &
Pages 703-709 | Received 08 Mar 2019, Accepted 20 Jun 2019, Published online: 28 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francesco Passiglia, Maria Lucia Reale, Valeria Cetoretta & Silvia Novello. (2021) Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?. ImmunoTargets and Therapy 10, pages 9-26.
Read now

Articles from other publishers (8)

Jing Zang, Jinniu Zhang, Yijun Mei, Yaoxuan Xiong, Tianyuan Ci & Nianping Feng. (2024) Immunogenic dead cells engineered by the sequential treatment of ultraviolet irradiation/cryo-shocking for lung-targeting delivery and tumor vaccination. Biomaterials Science.
Crossref
Chen Shi, Chen Jian, Lulu Wang, Chen Gao, Ting Yang, Zhiwen Fu & Tingting Wu. (2023) Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy. Journal of Nanobiotechnology 21:1.
Crossref
Yuting Lu, Tangye Zeng, Huamiao Zhang, Yang Li, Xiaoling Zhu, Huiping Liu, Beibei Sun, Chaoran Ji, Ting Li, Leyi Huang, Kesong Peng, Zhe Tang & Longguang Tang. (2023) Nano-immunotherapy for lung cancer. Nano TransMed 2:1, pages e9130018.
Crossref
Carlton Bijesh Ray, Vinesan Vijayarasa, Maariyah Vankad, Mohamed Sherif & Amer Harky. (2021) The role of immunotherapy in treating lung cancer: current status and future perspective. Future Drug Discovery 3:4.
Crossref
Meng Qiao, Tao Jiang, Xinyu Liu, Shiqi Mao, Fei Zhou, Xuefei Li, Chao Zhao, Xiaoxia Chen, Chunxia Su, Shengxiang Ren & Caicun Zhou. (2021) Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?. Journal of Thoracic Oncology 16:8, pages 1267-1288.
Crossref
Mahdi Dehghan-Manshadi, Amin Reza Nikpoor, Hossein Hadinedoushan, Fateme Zare, Mojtaba Sankian, Farzaneh Fesahat & Houshang Rafatpanah. (2021) Protective immune response against P32 oncogenic peptide-pulsed PBMCs in mouse models of breast cancer. International Immunopharmacology 93, pages 107414.
Crossref
Keman Cheng, Qinglin Kang & Xiao Zhao. (2020) Biogenic nanoparticles as immunomodulator for tumor treatment. WIREs Nanomedicine and Nanobiotechnology 12:6.
Crossref
Yingxuan Zhang, Zheyan Fang, Ruizhen Li, Xiaotian Huang & Qiong Liu. (2019) Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy. Cancers 11:9, pages 1314.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.